Bath & Body Works (NYSE:BBWI) Shares Down 5.5% – Time to Sell?

Bath & Body Works, Inc. ( NYSE:BBWI – Get Free Report )’s share price was down 5.5% during trading on Friday .

The company traded as low as $26.16 and last traded at $26.09.



Approximately 764,789 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 4,633,526 shares. The stock had previously closed at $27.62.

Wall Street Analysts Forecast Growth A number of research firms recently issued reports on BBWI. Piper Sandler upgraded Bath & Body Works from a “neutral” rating to an “overweight” rating and decreased their price objective for the stock from $38.00 to $35.

00 in a report on Wednesday. Robert W. Baird raised their price target on shares of Bath & Body Works from $45.

00 to $47.00 and gave the stock an “outperform” rating in a research note on Friday, February 28th. Telsey Advisory Group reissued an “outperform” rating and issued a $43.

00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Raymond James restated an “outperform” rating and set a $46.00 target price (up previously from $42.

00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Finally, Barclays lowered their price target on shares of Bath & Body Works from $43.00 to $38.

00 and set an “equal weight” rating on the stock in a research note on Monday, March 3rd. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.

com, the stock has an average rating of “Moderate Buy” and an average target price of $44.06. Check Out Our Latest Stock Report on Bath & Body Works Bath & Body Works Price Performance Bath & Body Works ( NYSE:BBWI – Get Free Report ) last posted its earnings results on Thursday, February 27th.

The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.

05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.

43%. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.

78 billion. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.

3 earnings per share for the current fiscal year. Bath & Body Works Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.

20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.

01%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s payout ratio is presently 21.

98%. Bath & Body Works announced that its Board of Directors has approved a stock repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares.

This buyback authorization authorizes the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Institutional Inflows and Outflows Institutional investors and hedge funds have recently bought and sold shares of the stock. D1 Capital Partners L.P.

bought a new stake in shares of Bath & Body Works during the fourth quarter worth approximately $109,797,000. Norges Bank acquired a new stake in Bath & Body Works during the 4th quarter worth approximately $73,572,000. Arrowstreet Capital Limited Partnership boosted its stake in Bath & Body Works by 79.

1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company’s stock valued at $150,507,000 after purchasing an additional 1,715,096 shares during the period. Alliancebernstein L.

P. boosted its stake in Bath & Body Works by 35.6% in the 4th quarter.

Alliancebernstein L.P. now owns 5,178,447 shares of the company’s stock valued at $200,768,000 after purchasing an additional 1,360,264 shares during the period.

Finally, Anomaly Capital Management LP grew its holdings in Bath & Body Works by 38.3% in the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company’s stock valued at $188,456,000 after buying an additional 1,346,752 shares in the last quarter.

Institutional investors and hedge funds own 95.14% of the company’s stock. Bath & Body Works Company Profile ( Get Free Report ) Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter ..